Report Highlights

U.S. Healthcare Quality Management: Market Overview

The U.S. healthcare quality management market reached USD 14.6 billion in 2024, and it differs from global norms because demand is set by federal payment policy rather than clinical preference. Medicare and Medicaid reimbursement rules convert quality measures into direct revenue consequences, so hospitals and health plans buy measurement infrastructure as a financial control. Nearly every acute care hospital reports data to CMS, creating a compliance-driven buying cycle that few global markets replicate.

Market structure also diverges sharply from Europe, where national registries and public agencies often supply quality data. In the U.S., buyers procure from a layered stack of vendors spanning benchmarking platforms, chart abstraction services, registry submission tools and EHR modules. Procurement is decentralized across roughly 6,000 hospitals and thousands of physician groups, which sustains a fragmented vendor landscape with no dominant supplier.

Growth Drivers Behind U.S. Quality Management Demand

The Hospital Value-Based Purchasing Program withholds 2 percent of Medicare base operating diagnosis-related group payments and redistributes them according to performance scores. This structure makes quality performance a direct margin variable for roughly 3,000 participating hospitals, prompting investment in abstraction, benchmarking and gap-closure analytics. Hospitals trailing peer percentiles face reimbursement losses that outweigh software costs, which keeps budgets for measurement tools resilient.

The Merit-based Incentive Payment System under the Quality Payment Program applies payment adjustments of up to plus or minus 9 percent for clinicians, extending quality accountability into physician groups and specialty practices. Simultaneously, the CMS Innovation Center's ACO REACH model and Medicare Advantage Star Ratings require continuous measure tracking across population cohorts. An aging population, with Medicare enrollment approaching 68 million beneficiaries, steadily expands the patient denominator that vendors must measure.

Market Restraints and Entry Barriers

Entrants face a dense regulatory perimeter when handling patient data. HIPAA privacy and security rules, administered by the HHS Office for Civil Rights, require business associate agreements with every hospital customer, and any abstraction workflow touching protected health information carries audit exposure. Peer review materials protected under the Patient Safety and Quality Improvement Act of 2005 also restrict how data can be shared with outside vendors, which lengthens onboarding timelines.

Incumbent advantage is entrenched. Vizient and Premier Inc. hold group purchasing contracts that bundle quality analytics into existing membership agreements, pricing standalone entrants out of competitive bids. Measure specifications change annually, and vendors must certify calculations against CMS and Joint Commission requirements, which demands costly validation cycles. Pricing pressure from consolidating hospital systems further compresses margins for newcomers.

Market Opportunities in the U.S.

The most accessible near-term opportunity sits in ambulatory surgical centers, which face CMS quality reporting obligations without the internal analytics teams that large hospitals maintain. Roughly 5,700 Medicare-certified ASCs operate nationally, and this segment represents an estimated USD 1.2 billion addressable spend for cloud-based measurement platforms by 2027. Entrants can win share through bundled submission tools priced per facility, which matches the purchasing behavior of independent operators.

Skilled nursing facilities represent a second opening. The Skilled Nursing Facility Quality Reporting Program requires submission of standardized assessment data and reduces the annual payment update by 2 percent for non-reporting providers. Vendors offering MDS-linked quality dashboards address a market of roughly 15,000 Medicare-certified facilities, and partnering with regional health systems for post-acute transitions offers distribution leverage.

Market at a Glance

Leading Market Participants

• Press Ganey Associates
• Vizient
• Premier Inc.
• Cotiviti
• Health Catalyst
• Epic Systems
• Optum
• NextGen Healthcare
• Iodine Software
• HealthStream

Regulatory and Policy Environment

The Medicare Quality Payment Program, governed by the Centers for Medicare and Medicaid Services, sets measure reporting rules through annual Physician Fee Schedule and Inpatient Prospective Payment System final rules. The CMS Promoting Interoperability program requires certified electronic health record technology, while the 21st Century Cures Act and the ONC Health Data, Technology and Interoperability rule prohibit information blocking, with enforcement handled through HHS.

The Joint Commission and the National Committee for Quality Assurance impose parallel accreditation obligations, and NCQA administers HEDIS measures used in Medicare Advantage Star Ratings. Compliance timelines are fixed: CMS typically publishes final rules in late summer or fall, reporting periods begin January 1, and submission deadlines fall in the first half of the following year. Vendors must update measure logic before each annual reporting period opens.

Long-Term Outlook for U.S. Quality Management

By 2032 the market is forecast to reach USD 27.8 billion at an 8.4 percent compound annual growth rate, with growth concentrated in cloud-based, EHR-embedded measurement. Standalone abstraction services will decline as Epic Systems and Oracle Health absorb routine calculations, forcing specialist vendors toward predictive analytics and value-based contract management.

Value-based care penetration will determine vendor structure by 2032. Medicare Advantage enrollment, which already exceeds half of eligible beneficiaries, will push health plans toward outcome-linked quality platforms. Consolidation among mid-tier vendors will accelerate, and buyers will concentrate spend on fewer platforms as reporting obligations become more uniform across payers.